|
Virginia Acha |
Biography:
Virginia (Ginny) has worked in industry and academia throughout her career, combining interests in science policy research and innovation performance within and across organizations. She joined MSD in 2017 to lead regulatory policy efforts for innovation that will lead to better treatment for patients globally. Before joining MSD, Ginny was the senior spokesman for the industry in the UK for research, medical and innovation policy (including BREXIT). Previously, Ginny worked for Amgen in global regulatory policy and for Pfizer working on policy development in science and innovation in healthcare. |
|
|
|
|
Atholl Johnston |
Biography:
Professor Atholl Johnston is Professor of Clinical Pharmacology at
Barts and The London School of Medicine and Dentistry, Queen Mary’s,
University of London, visiting Professor of Forensic Pharmacology
and Toxicology at St George’s, University of London, and the
Director of the laboratory of Analytical Services International Ltd.
He is a Fellow of the British Pharmacological Society, the Royal
College of Pathologists, the Royal Society of Medicine, the Faculty
of Pharmaceutical Medicine, and the Royal Statistical Society. He is
a Chartered Scientist, a European Registered Toxicologist, and a
state registered Clinical Scientist.
Professor Johnston has more than 35 years’ experience in the
measurement of drugs as a guide to therapy. He has published over
two hundred and sixty articles in peer-reviewed journals.
Professor Johnston was a Founder member of CCRA and is currently its
President. |
|
|
|
|
Emma Lowe |
Biography:
Emma works within the Science Research and Evidence Directorate the
Department of Health and Social Care. Her role includes leadership
of the UK Clinical Research Recovery Resilience and Growth
programme, supporting the implementation of the Life Sciences
Vision, enhancing the National Institute for Health and Care
Research (NIHR) offer for Industry, and other areas of policy which
contribute to making the UK the destination of choice for life
sciences research.
Emma is a participant in the Academy of Medical Sciences FLIER
programme, has an MSc in People and Organisational Development from
the Roffey Park Institute and previously led the design and delivery
of learning and workforce development programmes in the NIHR
Clinical Research Network, including the NIHR’s Good Clinical
Practice (GCP) programme. |
|
|
|
|
Fiona Maini |
Biography:
Fiona has worked within the Life Sciences and Healthcare domain for
over 20 years. Her focus at Medidata includes strategy and advocacy
pertaining to the interface of technological advances and regulatory
evolution in clinical research. She regularly interacts with
authorities and industry bodies on modern technology strategies, in
particular patient centric technologies. Prior to Medidata Fiona was
a Director at Deloitte, leading the Deloitte Global Centre for
Regulatory Excellence for Life Sciences and provided governance of
Deloitte services to the EMA and their programmes. |
|
|
|
|
Ben McConnochie |
Biography:
Ben McConnochie is the Director of Strategic Development for
Medidata AI. He is responsible for the go to market for Medidata
Link (RWD to Clinical Trial linkage solution), supporting
organizations in building their data linkage and RWD strategies.
Over the last ten years at Medidata and IQVIA Ben has specialized in
designing and delivering innovative solutions using diverse
combinations of real world and clinical trial data to support
clinical development and health systems engagement. Ben has a
masters in Genetics from the University of Nottingham. |
|
|
|
|
Janet Messer |
Biography:
Janet Messer is Director of Approvals Service at the Health Research
Authority. She is responsible for the Research Ethics,
Confidentiality Advice, Assessment and Assurance services, alongside
the supporting guidance, advice and learning functions. Her team
works collaboratively with a wide range of partner organisations to
fulfil the HRA’s aims to make it easier to do good quality ethical
research in the UK. Prior to working at the HRA she was Head of
Research Management and Governance at the NIHR Clinical Research
Network. She has a PhD in biochemistry from University of Cambridge
and a Masters in Medical Law, along with many years’ experience of
clinical research in the pharmaceutical industry and working with
NHS R&D. |
|
|
|
|